InVivoMAb anti-mouse CTLA-4 (CD152)
BE0032
ApplicationsFlow Cytometry, Western Blot, Neutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse CTLA-4 (CD152)
- Delivery Days Customer7
- ApplicationsFlow Cytometry, Western Blot, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDUC10-4F10-11
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostHamster
- IsotypeIgG
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Triplett TA, Garrison KC, Marshall N, et al. Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme. Nat Biotechnol. 2018,36(8):758-764. doi: 10.1038/nbt.4180Read this paper
- Welten SP, Redeker A, Franken KL, et al. The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion. Elife. 2015,4. doi: 10.7554/eLife.07486Read this paper
- Makkouk A, Joshi VB, Lemke CD, et al. Three steps to breaking immune tolerance to lymphoma: a microparticle approach. Cancer Immunol Res. 2015,3(4):389-98. doi: 10.1158/2326-6066.CIR-14-0173Read this paper
- Pletinckx K, Vaeth M, Schneider T, et al. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4. Eur J Immunol. 2015,45(2):480-91. doi: 10.1002/eji.201444991Read this paper
- Zhu Y, Knolhoff BL, Meyer MA, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014,74(18):5057-69. doi: 10.1158/0008-5472.CAN-13-3723Read this paper
- Mittal D, Young A, Stannard K, et al. Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor. Cancer Res. 2014,74(14):3652-8. doi: 10.1158/0008-5472.CAN-14-0957Read this paper
- Rabenstein H, Behrendt AC, Ellwart JW, et al. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells. J Immunol. 2014,192(8):3507-17. doi: 10.4049/jimmunol.1302725Read this paper
- Honda T, Egen JG, Lämmermann T, et al. Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues. Immunity. 2014,40(2):235-247. doi: 10.1016/j.immuni.2013.11.017Read this paper
- Allard B, Pommey S, Smyth MJ, et al. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs. Clin Cancer Res. 2013,19(20):5626-35. doi: 10.1158/1078-0432.CCR-13-0545Read this paper
- Hafalla JC, Claser C, Couper KN, et al. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. PLoS Pathog. 2012,8(2):e1002504. doi: 10.1371/journal.ppat.1002504Read this paper
Datasheet
Related products
Product group Antibodies
ApplicationsWestern Blot, Neutralisation/Blocking
- SizePrice
Product group Antibodies
ApplicationsWestern Blot, Neutralisation/Blocking
- SizePrice
Product group Antibodies
ApplicationsWestern Blot, Neutralisation/Blocking
- SizePrice
Product group Antibodies
ApplicationsWestern Blot, Neutralisation/Blocking
- SizePrice
Product group Antibodies
ApplicationsFlow Cytometry, Western Blot, ELISA, Neutralisation/Blocking
- SizePrice
Product group Antibodies
References
ApplicationsWestern Blot, Neutralisation/Blocking
- SizePrice
Product group Antibodies
References
ApplicationsWestern Blot, Neutralisation/Blocking, Other Application
- SizePrice
Product group Antibodies
References
ApplicationsFlow Cytometry, Neutralisation/Blocking
- SizePrice